Erectile Dysfunction

Erectile Dysfunction (ED) is defined as the consistent inability to attain and maintain an erection sufficient for satisfactory sexual intercourse. ED affects up to 30 million men in the United States, with 52% of men between the ages of 40 and 70 reporting difficulty with erectile function. By the year 2025, it is estimated that 322 million men worldwide will suffer from some degree of sexual dysfunction.

What is Impotence (Erectile Dysfunction)?

Erectile dysfunction is known in common parlance as impotence. It signifies the inability to get and maintain an erection necessary for a satisfactory sexual intercourse. This is a fairly common condition and affects a large majority of men over 40.

Erectile Dysfunction, Causative Factors and Complications

Impotence (Erectile Dysfunction) Diagnosis

Impotence (Erectile Dysfunction) Treatments

Impotence (Erectile Dysfunction) History

Impotence (Erectile Dysfunction) Symptoms

How To Talk To Your Partner About Erectile Dysfunction

Does Erectile Dysfunction Reduce Productivity?

Regenerative Therapy for Erectile Dysfunction

Latest Erectile Dysfunction News and Research

Why millions are trying FDA-authorized alternatives to big pharma’s weight loss drugs

Pharmacist Mark Mikhael has lost 50 pounds over the past 12 months. He no longer has diabetes and finds himself "at my ideal body weight," with his cholesterol below 200 for the first time in 20 years. "I feel fantastic," he said.

23 Jul 2024

FDA approved PDE4 inhibitor roflumilast for atopic dermatitis

On July 9th, 2024, the U.S. FDA approved Arcutis Biotherapeutics' ZORYVE® (roflumilast) for treating atopic dermatitis (AD), the most common type of eczema affecting millions in the U.S. This once-daily, steroid-free cream could become a new standard of care for AD.

From Sino Biological Inc. 12 Jul 2024

New study reveals the genetic cause of Parkinson's disease

According to Science Alert, neuroscientists from Johns Hopkins University have recently discovered a new treatment for Parkinson's disease using an FDA-approved cancer drug.

11 Jul 2024

Study suggests shift work increases risk of premature ejaculation in men

A recent study links shift work and shift work sleep disorder (SWSD) to an increased risk of premature ejaculation (PE) in male workers. The findings highlight how sleep disruptions and prolonged shift work impact reproductive health.

7 Jul 2024

Research explores reversing memory loss with existing drugs

The loss of social memories caused by sleep deprivation could potentially be reversed using currently available drugs, according to a study in mice presented today (Friday) at the Federation of European Neuroscience Societies (FENS) Forum 2024.

28 Jun 2024

Body image and overall health found important to the sexual health of older gay men, according to new studies

According to a National Poll on Healthy Aging, 93% of people in the U.S. between 50-80 years old report experiencing at least one form of ageism from other people.

21 Jun 2024

Research finds microplastics in human penile tissue

The accumulation of microplastics in penile tissue to determine potential toxicity concerns.

21 Jun 2024

Study confirms no causal link between COVID-19 and ischemic priapism

A study in the International Journal of Impotence Research found no causal link between COVID-19 and ischemic priapism, with priapism occurring across all COVID-19 severity levels and treatments remaining effective.

13 Jun 2024

Natural antioxidants could delay age-related decline in male testosterone production

Natural polyphenolic compounds to enhance testosterone production and prevent age-related hypogonadism in aging males.

12 Jun 2024

Glowing marker dye gives medics a 'second pair of eyes' during prostate cancer surgery

A glowing marker dye that sticks to prostate cancer cells could help surgeons to remove them in real-time, according to a study funded by Cancer Research UK.

10 Jun 2024

Does cannabis use cause erectile dysfunction?

Study found no causal link between cannabis use and erectile dysfunction or changes in sex hormone levels using Mendelian randomization analysis.

7 Jun 2024

Long COVID linked to higher risk of erectile dysfunction, new study finds

The risk of developing erectile dysfunction (ED) following a diagnosis of long coronavirus disease (COVID) compared to acute COVID.

4 Jun 2024

COVID-19 associated with higher risk of erectile dysfunction

Men previously diagnosed with COVID-19 are at a greater risk of developing new-onset erectile dysfunction.

31 May 2024

Increased risk of erectile dysfunction with semaglutide in non-diabetic obese patients

Researchers found that semaglutide treatment for weight loss in non-diabetic, obese men is associated with an increased risk of erectile dysfunction and testosterone deficiency.

26 May 2024

Study uncovers sex differences in brain responses to low sexual desire

Study reveals that women with Hypoactive Sexual Desire Disorder (HDSS) show a "top-down" brain inhibition pattern, while men do not, suggesting significant sexual dimorphism in brain responses to sexual stimuli.

16 May 2024

Generation Z urged to prioritize gum health

As Generation Z embarks on their journey into adulthood, there's one crucial aspect of their health that can sometimes be overlooked: their gums.

30 Apr 2024

Three-step prostate cancer screening method demonstrates reduced overdiagnosis

A large randomized trial conducted at Tampere University and the University of Helsinki shows that a new three-step prostate cancer screening method can find a considerable number of aggressive cancers.

10 Apr 2024

Plant-based diet linked to less erectile dysfunction, urinary incontinence in prostate cancer patients

A diet that limits meat and dairy but is rich in fruits, vegetables, grains, and nuts is linked to less erectile dysfunction, urinary incontinence, and other common side effects seen in prostate cancer patients, a new study shows.

13 Feb 2024

Study finds erectile dysfunction drugs linked to lower Alzheimer's risk

Researchers evaluated the effect of phosphodiesterase-5 inhibitor (PDE5I) initiation compared to non-use and Alzheimer's disease development risk among males suffering from erectile dysfunction.

12 Feb 2024